Objective: The gene TSPAN8 was recently identified in a genome-wide association study as the most likely causal gene in a locus that was correlated with the risk of type 2 diabetes (T2D) in northern European individuals. To assess whether Tspan8 is the actual T2D-causal gene in this locus, we ablated its expression in mice and determined the consequences of this ablation on a multitude of metabolic traits. Results: We found that genetic ablation of Tspan8 in mice results in a reduction (À15.6%) in the body weight of males fed a normal chow diet and that this deficiency results in a resistance to body weight gain (À13.7%) upon feeding a high fat and high carbohydrate diet. The differences in body weight could only be detected in male mice and were the consequence of both a decrease in fat deposition, and a decrease in lean body mass (16.9 and 11%, respectively). In spite of the significant body weight difference, no changes in fasting insulin and glucose levels could be detected in Tspan8 knockout mice, nor could we identify changes in the clearance of glucose or sensitivity to insulin in oral glucose tolerance test and intraperitoneal insulin sensitivity test studies, respectively. In addition, male Tspan8 knockout mice showed significantly lower bone mineral density and phosphorus levels (6.2 and 16.6%, respectively). Expression of Tspan8 in mouse was highest in digestive tissues, but virtually absent from the pancreas. In contrast, expression of human TSPAN8 was substantial in digestive tissues, as well as pancreatic cells. Conclusions: Our results argue for a role for Tspan8 in body-weight regulation in males, but do not show differences in T2D-associated traits that were anticipated from previous human genome-wide association studies. Differences in Tspan8 expression levels in mouse and human tissues suggest that Tspan8 could fulfill different or additional physiological functions in these organisms.
Introduction
Recent genome-wide association studies (GWAS) have identified a number of loci that correlate with an increased risk of type 2 diabetes (T2D). [1] [2] [3] [4] [5] Most loci identified in these studies showed moderate effects on disease risk, with odds ratios varying from 1.14 for KCNJ11 to B1.35 for TCF7L2. 1, 6 It is evident that the small effect sizes of common gene variants have made it difficult to identify additional loci involved in the pathogenesis of disease and show the need for larger patient cohorts. A meta-analysis carried out by the Diabetes Genetics Replication And Meta-analysis consortium, combined the GWAS data from three independent studies that allowed for an increase in the analytical power to detect loci with modest effects on disease risk. 7 This analysis resulted in the identification of six more loci that correlated with an increased risk for T2D. One of the identified T2D risk loci, located on chromosome 12q15, consists of a haploblock containing the genes TSPAN8, LGR5 and PTPRR. Close examination of the haploblock structure with the inclusion of additional single-nucleotide polymorphisms suggests TSPAN8 as the most likely T2D causal gene in this region. 7 In an independent cohort of 4516 glucose-tolerant Danes, 8 this 12q15 locus associated significantly with intermediary traits of T2D, such as the release of insulin during an oral glucose tolerance test (OGTT). However, no association of this locus with prediabetic traits could be identified in Southern German individuals at an increased risk for T2D; 9 replication of this T2D risk locus could also not be established in a Japanese cohort and an Asian Indian Sikh population containing type 2 diabetics. 10, 11 None of the three genes in the T2D risk locus 12q15 (LGR5, PTPRR and TSPAN8) have previously been shown to have a role in the onset or progression of T2D.
LGR5 encodes a Gprotein coupled receptor possibly involved in tumor formation, 12 whereas PTPRR encodes a protein tyrosine phosphatase possibly involved in neuronal growth and differentiation. 13 TSPAN8 is a member of the tetraspanin transmembrane protein family. Tetraspanins are similar in size (20) (21) (22) (23) (24) (25) (26) (27) (28) (29) (30) , share a common topology (four transmembrane domains, one small and one large extracellular loop) and contain common protein motifs, such as conserved cysteine residues involved in the formation of disulfide bridges and palmitoylation sites. 14, 15 Tetraspanins have been shown to have different functions in diverse biological processes, varying from cell signaling and adhesion to tumor formation. TSPAN8 has been suggested to have a role in the formation of exosomes and has been shown to promote tumor invasion in vitro. 15 However, a role for TSPAN8 in the onset or progression of T2D has never been established. To identify the actual T2D-causal gene in the 12q15 locus, several approaches are possible. One would be to resequence the chromosomal region of interest in the patient populations in which it was initially identified as causal and identify nonsense or missense mutations that cosegregate with the disease. 16 An alternative approach would be to perturb the expression or activity of the most likely gene candidate in an animal model and determine its effect on the trait of interest. This latter approach has the additional benefit of gaining more insight into the biological role of the gene in question. In this study, we report on the generation of Tspan8 knockout mice and the consequences of Tspan8 deletion for multiple metabolic traits.
Materials and methods

Generation of Tspan8 knockout mice
The Tspan8 knockout mice (Line T1684; Genbank accession; gi:20988253) were generated at Deltagen (San Mateo, CA, USA). The generated Tspan8 knockout mice were backcrossed at least six generations to C57Bl/6 mice (98.4% B6N, 1.6% SVJ129). Wild-type littermates were used as controls in all studies described below.
Phenotypic analysis of Tspan8 KO mice All animal procedures described were approved by the Merck Research Laboratories (Rahway, NJ, USA) and Institutional Animal Care and Use Committee, and were in conformity with Public Health Service policy on humane care and use of laboratory animals.
Body weights
Body weights were monitored weekly, between 6 and 17 weeks of age. 
Insulin sensitivity test
An insulin sensitivity test was performed on 19-week-old mice that were fed a HFHC diet for 10 weeks, followed by a 16-h fasting period. After measurement of the basal glucose level on a drop of blood collected from the tail (time 0), mice were injected intraperitoneally with a solution of insulin (Umuline RapideFEli Lilly) in a sterile saline solution (0.9% NaCl) at a dose of 0.5 UI kg -1 . To determine the glucose concentration, blood was collected from the tail at 15, 30, 45, 60 and 90 min after injection of the insulin solution.
Blood sample analysis
Blood was collected from 4-h fasted mice in the morning by retro orbital puncture under isofluorane anesthesia. Blood parameters were determined on 9-week-old mice (fed a standard chow diet) and 25-week-old mice (fed a HFHC diet for 16 weeks) using an Olympus AU400 analyzer (Olympus SA, Rungis, France) with kits and controls supplied by Olympus for total cholesterol, high-density lipoprotein (HDL)-cholesterol and triglyceride measurements. Free fatty acid levels were measured on the Olympus AU400 using a kit from Wako (Wako Chemical , Richmond, VA, USA) and glycerol, using a kit from Randox Laboratories (Crumlin, UK). Internal quality control materials (Olympus) were analyzed on a daily basis to monitor our precision throughout the experiment.
Lipoprotein profiling of serum from Tspan8 knockout mice To generate lipoprotein profiles, plasma or serum was fractionated by chromatography over Superose-6 size exclusion column (GE Healthcare, Piscataway, NJ, USA).
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Total cholesterol levels in the column effluent were continuously measured by in-line mixture with a commercially available enzymatic colorimetric cholesterol detection reagent (total cholesterol E, Wako Chemical) followed by downstream spectrophotometric detection of the reaction products at 600 nm absorbance. The first peak of cholesterol that eluted from the column was attributed to very lowdensity lipoprotein, the second peak to low-density lipoprotein (LDL) and the third to HDL; the area under each peak was calculated using software provided with the highperformance liquid chromatography. To calculate the cholesterol concentration for each lipoprotein fraction, the ratio of the corresponding peak area to total peak area was multiplied by the total cholesterol concentration measured in the sample. Serum ApoB concentrations were determined using a similar Enzyme-Linked immunosorbent assay protocol; the capture antibody (rabbit polyclonal anti-mouse ApoB; SDI; Newark, DE, USA) was used at 10 mg ml -1 . Samples were diluted 1:400. The detection antibody was a biotinylated rabbit polyclonal anti-mouse ApoB antibody (produced by SDI) used at 1 mg ml -1 . Purified mouse LDL was used as a standard. Serum Pcsk9 concentrations were determined using a similar Enzyme-Linked Immunosorbent Assay protocol; the capture antibody (H23; mouse monoclonal anti-mouse Pcsk9; generated in house) was used at a concentration of 10 mg ml -1 . Samples were diluted 1:8. The detection antibody was a biotinylated mouse monoclonal anti-mouse Pcsk9 antibody (B20; generated in house), used at 1 mg ml -1 . Purified, recombinant mouse Pcsk9 (BlueSky Biotech, Worcester, MA, USA) was used as a standard.
RNA isolation from tissue and Tspan8 RNA expression analysis Livers from mice were isolated and immediately snap-frozen in liquid nitrogen. RNA was isolated using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) according to the manufacturer's instructions. After the ethanol precipitation step in the TRIzol extraction procedure, a cleanup of the RNA sample was performed using Promega SV Total RNA Isolation System (Promega, Madison, WI, USA). Total RNA concentration and purity were assessed by spectrophotometric analysis on a NanoDrop ND-1000 (NanoDrop, Wilmington, DE, USA).
Microarray profiling experiments using human and mouse tissues to assess Tspan8 expression levels was carried out essentially as described. 19, 20 Results
Generation of Tspan8 knockout mice
To determine whether Tspan8 could be the actual causal gene in the T2D risk locus 12q15 in humans and to gain further insight into the physiological role of this gene, we studied the effect of ablating its expression in the mouse. Through homologous recombination with a Neomycin-LacZ cassettecontaining targeting vector, 56 base pairs of the third Tspan8 exon were deleted, resulting in a reading frame shift in the Tspan8 gene (see Figure 1a ). The mutant allele encodes a truncated form of the first 51 amino acids, which includes the first transmembrane domain of TSPAN8 only and should, therefore, render a non-functional protein.
Southern blot analysis of embryonic stem cell DNA confirmed the intended genomic disruption of the Tspan8 gene ( Figure 1b ). In addition, multiplex PCR carried out on genomic tail DNA from the generated mice showed a fragment pattern that was in line with the intended targeting strategy ( Figure 1c) .
The Neomycin-LacZ cassette used for this targeting strategy contains its own promoter and translation termination and polyadenylation sequences. In addition, this targeting strategy leads to the introduction of a premature stop codon in the Tspan8 gene, thereby making the resulting transcript a substrate for nonsense-mediated RNA decay. We, therefore, anticipated a total lack of Tspan8 expression in the generated knockout mice, which was confirmed by quantitative reverse transcriptase-PCR analysis on hepatic mRNA from male Tspan8À/À mice ( Figure 1d ).
Mice that were homozygous for the 56 base pair deletion in the Tspan8 gene were fertile and viable and did not show any major abnormalities. Also the genotype distribution of the F2 offspring was in agreement with a Mendelian distribution, which indicated that Tspan8À/À ablation had no detrimental effect in the mouse.
Body weight and composition of Tspan8 knockout mice
We backcrossed the generated Tspan8 knockout mice to C57Bl/6 for six generations (obtaining 98.4% B6N, 1.6% SVJ129 mice) and subjected them to extensive phenotypic analyses, using wild-type littermates as controls. The body weight of Tspan8À/À and wild-type mice was monitored on a A role for Tspan8 in body weight control M-F Champy et al weekly basis, from the age of 6 to 17 weeks. At 9 weeks of age, mice were switched from a normal chow diet to a HFHC diet. A significant difference in body weight was already apparent in 6-week-old male Tspan8À/À mice, as compared with wildtype littermates (Figure 2a ). This difference in body weight increased upon feeding the HFHC diet at 9 weeks of age and reached 15.6% by the age of 17 weeks. Food intake was the same for both Tspan8À/À and wild-type mice (not shown), and could, therefore, not account for the lower body weight of male Tspan8À/À mice. No significant difference in body weight could be detected between female Tspan8À/À and wild-type mice (Figure 2a ).
To determine which tissues contributed to the lower body weight phenotype in the male Tspan8À/À mice, we carried Figure 1 Targeted disruption of the mouse Tspan8 gene. (a) Targeting strategy. Shown are the structures of the targeting construct, the wild-type allele and the disrupted (mutant) Tspan8 allele. Homologous recombination of the targeting construct with the wild-type allele on chromosome 10 results in the replacement of 56 base pairs in exon 3 of Tspan8 by a Neomycin-LacZ (Neo) cassette. This Neo-lacZ cassette contains KpnI (K) and PstI (P) restriction sites, which can be used in Southern blot analysis of genomic embryonic stem (ES) cell and tail DNA. (b) Southern blot of genomic DNA isolated from embryonic stem cells, digested with KpnI (lanes 2-4) or PstI (lanes 5-7) and hybridized with a DNA fragment located outside of the 3 0 arm of the targeting construct (indicated in A). Lane 1: molecular weight marker. Lanes 2, 3, 5 and 6 contain genomic DNA from parental ES cells; lanes 4 and 7 contain DNA isolated from ES cells (line 1684) that were used for generation of the described knockout mice. E: endogenous Tspan8 fragment; T: targeted Tspan8 fragment. (c) Genomic PCR on tail DNA from wild type (W), heterozygous (H) and homozygous (K) mutant Tspan8 mice. The left-hand panel (lanes 1-6) shows a schematic of expected PCR fragment patterns and sizes. The right-hand panel (lanes 7-28) shows the actual generated PCR fragments. All odd-numbered lanes show multiplexed PCR reactions with three primers that allow for the identification of both the wild type as well as the mutant allele. All even-numbered lanes show PCR reactions with two primers that recognize the endogenous (E) Tspan8 allele only. DNA extracted from wild type (WT DNA) and targeted ES cells (ES DNA) were used as controls (lanes 23 þ 24 and 25 þ 26, respectively). A role for Tspan8 in body weight control M-F Champy et al out quantitative nuclear magnetic resonance on 24-week-old mice that had been fed a HFHC diet for 15 weeks. As shown in Figure 2b , the loss of total body weight in male Tspan8À/À mice was due to a decrease in both fat tissue mass, as well as lean tissue mass (16.9 and 10.9%, respectively). The latter decrease could be ascribed to a lower muscle mass in the Tspan8À/À mice. Again, no differences could be found in lean tissue and fat tissue mass between female Tspan8À/À and wild-type mice (Figure 2c ).
Plasma glucose levels and OGTT in Tspan8 knockout mice Given the association of adiposity and body mass index with T2D and the suggested association of TSPAN8 with T2D in human GWAS, we determined several diabetes parameters in the Tspan8 knockout mice. Both male and female Tspan8 knockout mice displayed normal glucose levels at 9 weeks of age on a regular chow diet, as well as at 25 weeks of age after 16 weeks on a HFHC diet (Figure 3a) . When 17-week-old male mice (fed a HFHC diet for 8 weeks) were subjected to an OGTT, A role for Tspan8 in body weight control M-F Champy et al the rate of glucose clearance was not statistically different between Tspan8À/À and wild-type mice (Figure 3b ). Similar results were found for 17-week-old female mice (Figure 3c ).
Plasma insulin levels and intraperitoneal insulin sensitivity test of Tspan8 knockout mice
We also measured plasma insulin levels in Tspan8 knockout mice and found lower insulin concentrations in 9-week-old and 25-week-old male mice compared with wild-type mice, although the statistical significance for this difference was low (Figure 4a ; P40.05). No differences could be detected between female Tspan8À/À and wild-type mice. Fasted, 19-week-old male mice that had been fed a HFHC diet for 10 weeks were also subjected to an intraperitoneal insulin sensitivity test. As shown in Figure 4b , no difference could be detected in the clearance of glucose upon administration of insulin between male Tspan8À/À and wild-type A role for Tspan8 in body weight control M-F Champy et al mice. Similar results were obtained for female Tspan8À/À mice ( Figure 4c ).
Plasma free fatty acids and glycerol levels
Our phenotypic analyses also revealed reduced free fatty acid and glycerol levels in the plasma of male Tspan8À/À mice (Figures 5a and b, respectively) . Significantly lower free fatty acid levels could readily be detected in 9-week-old mice on a normal chow diet and were yet more pronounced in 25-week-old mice on a HFHC diet for 16 weeks (11.4 and 22.6%, respectively). Similarly, glycerol levels were decreased by 31.1% in 25-week-old male Tspan8À/À mice after HFHC feeding for 16 weeks (Figure 5b ). We could not detect any significant differences in free fatty acid and glycerol levels in the plasma of female Tspan8À/À mice (not shown). A role for Tspan8 in body weight control M-F Champy et al Lipoprotein profile of Tspan8 knockout mice As body weight changes have been correlated with changes in plasma concentrations of lipoproteins, we assessed the lipoprotein levels of Tspan8 knockout mice. To obtain information on the nature of cholesterol-containing particles (HDL, LDL and very low density lipoprotein), the plasma of these mice was subjected to size exclusion chromatography. These lipoprotein profile analyses showed no statistically significant differences in the serum levels of total cholesterol, HDL, LDL or very low density lipoprotein between wild type and Tspan8 knockout mice ( Table 1 ). Given that cholesterol levels in lipoprotein fractions are not necessarily a direct measure of the number of circulating particles, we measured circulating protein levels of ApoB and ApoAI in parallel (Table 1) . Neither for ApoB nor for ApoAI could we detect significant differences in plasma concentrations in Tspan8 knockout mice, for either gender ( Table 1 ), indicating that the number of lipoprotein particles is unaltered in Tspan8 knockout mice. Our measurements included circulating levels of Pcsk9, which has been described to influence plasma LDL levels by post-translational regulation of hepatic LDL receptor protein levels ( Table 1) . Also these measurements showed no differences in plasma concentrations between Tspan8 knockout and wild-type mice. Taken together, these results rule out a role for Tspan8 in the metabolism of lipoprotein particles.
Bone density of Tspan8 knockout mice Dual X-ray analysis allows for the measurement of bone density in live mice. We used this technology to assess the bone mineral density in 8-week-old male mice and found significant (6.2%) decreases in Tspan8À/À mice compared with wild-type littermates (Figure 6a ). After feeding a HFHC diet for 16 weeks, plasma calcium and phosphorus concentrations were measured in 25-week-old mice and were found to be significantly lower (3.4 and 16.6%, respectively) in male Tspan8À/À mice compared with wild-type mice (Figures 6b and c) . No changes in calcium and phosphorus levels could be found in female Tspan8À/À mice (data not shown).
Tspan8 expression analysis
To gain insight into the possible physiological role of Tspan8, we conducted RNA expression studies using micro array analysis. The expression of mouse Tspan8 mRNA was found to be high in cells in the digestive system, such as the stomach, the ileum and the jejunum of the small intestine, as well as the colon (Figure 7a ). In addition, mouse Tspan8 Tspan8À/À mice. Plasma levels of free fatty acids (a) and glycerol (b) were measured in 9-week-old mice on chow diet and 25-week-old male mice on a HFHC diet for 16 weeks, respectively, after being fasted for 4 h. Depicted are average fatty acid or glycerol values ± s.e.m. from nine male Tspan8À/À and nine male wild-type littermate mice. *P ¼ 0.05. **Po0.01. Abbreviations: ApoAI, apolipoprotein AI; ApoB, apolipoprotein B; HDL, high-density lipoprotein; LDL, low-density lipoprotein; TC, total cholesterol; WT, wild type; VLDL, very low-density lipoprotein. Serum was isolated from 16-week-old, 4 h-fasted mice that were fed a high fat, high carbohydrate diet for 10 weeks. One serum aliquot was subjected to total cholesterol (TC) measurement, the remainder was subjected to size exclusion chromatography. Continuous cholesterol detection of the eluate allowed for the determination of cholesterol in the HDL, LDL and VLDL fractions. Serum was also subjected to the measurement of ApoB, ApoAI or Pcsk9 by use of ELISA-based detection methods described in the Materials and methods section. Depicted are average values ± s.e.m. from 10 male wildtype (WT), eight male Tspan8À/À, nine female wildtype and seven female Tspan8À/À mice.
A role for Tspan8 in body weight control M-F Champy et al mRNA expression could also be detected in the lung, prostate, gallbladder and seminal vesicles, whereas Tspan8 expression was virtually absent from the pancreas (Figure 7a ). In contrast, expression of human TSPAN8 was prominent in the pancreas, as well as in tissues of the digestive track (stomach, duodenum, jejunum and ileum of the small intestine) and lung and prostate (Figure 7b ).
Discussion
The use of GWAS has shown to be an invaluable tool for the identification of genes involved in the pathogenesis of human disease. 5, 21 The gene TSPAN8 was recently identified as the most likely causal gene in a locus that was correlated with the risk of T2D (T2D) in northern European individuals. 7 In this study we show that Tspan8 deficiency results in a lower body weight in male mice fed a normal chow diet, and in a lower gain in body weight upon feeding a HFHC diet. These differences in male body weight gain were the consequence of both a lower gain in fat mass, as well as a lower gain in lean body (muscle) mass. As the body length of the generated Tspan8 knockout mice was unchanged and no gross abnormalities could be detected, the lower body weight of these knockout mice is not likely to be due to growth retardation or developmental defects caused by a Tspan8 deficiency. It does, however, not rule out the possibility that Tspan8 is involved in the uptake of nutrients from the diet, such as fatty acids or other biomolecules, which could subsequently result in less storage of fat in adipose tissue and a lower availability of energy for muscle tissues.
No significant body weight differences could be detected for female Tspan8 knockout mice nor could any differences in fat or lean tissue mass be detected in female knockouts. The observed gender-specific disparities in body weight and fat mass could possibly be explained by the action of sex hormones that differentially regulate the rate of lipolysis and lipogenesis in males and females. [22] [23] [24] Sex hormones have been described to regulate the distribution, as well as the amount of adipose tissues through genomic and nongenomic mechanisms, by regulating the transcription of genes and the activity of lipolytic proteins, respectively.
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Tspan8 could have a role in altering the levels of sex hormones or their action on metabolic processes. Also the decrease in bone mineral density that was detected in male Tspan8 knockout mice could be the consequence of sex hormone regulation. Deficiencies in both androgen and estrogen production have been shown to have direct effects on the resorption of bone in both female as well as in male mice. 26, 27 In addition, human males with a deficiency in the aromatase gene suffer from bone loss, which can be reversed by estrogen replacement therapy. [28] [29] [30] Alternatively, Tspan8 could be involved in the regulation of calcium absorption from the diet, either directly or indirectly, which in Tspan8-deficient mice results in a reduction in calcium absorption and thus lower incorporation into bone. This possibility will be discussed in more detail below. In addition to the body weight and bone density phenotypes, male Tspan8 knockout mice also exhibited lower circulating levels of free fatty acids and glycerol, both under normal chow diet and HFHC diet conditions. These decreases are not likely to be the consequence of changes in hepatic triglyceride synthesis, given that plasma levels of triglycerides were unaffected in Tspan8 knockout mice. A role for Tspan8 in body weight control M-F Champy et al
Rather, these changes are conceivably the consequence of diminished lipolysis either due to a decrease in adipocyte signaling or activation or due to a lower total fat mass per se. A surprising finding in our studies was that in spite of the significant decrease in body weight and fat deposition in male Tspan8 knockout mice, no changes in fasting insulin and glucose levels could be detected. Also no differences in the clearance of glucose in an OGTT experiment nor the sensitivity to insulin in an intraperitoneal insulin sensitivity test study was found in these knockout mice. Although our experiments extended up to 26 weeks (19 of which on a HFHC diet), it is possible that a more prolonged study is needed to detect an effect on insulin sensitivity or glucose clearance in male Tspan8 knockout mice. This seems unlikely, however, as identical feeding paradigms have been used successfully in our laboratories to detect differences in glucose tolerance and insulin sensitivity in knockout mice with a body weight phenotype (not shown).
Our findings seem at odds with a role for TSPAN8 in the onset or progression of T2D in humans, as suggested by its identification in a locus that correlated with increased risk for T2D in a GWAS. 7, 8 Several explanations might account for this discrepancy. First, TSPAN8 might not be the actual causal gene for the increased T2D risk identified in humans. The identified T2D risk locus was shown to contain three genes, of which TSPAN8 was the most likely candidate, due to its location in the haploblock and the proposed biological roles of the other two genes (LGR5 and PTPRR). However, both LGR5 and PTPRR could qualify as the actual causal gene, albeit with a much lower probability. Full disclosure on the nature of the actual causal gene can be obtained by resequencing the risk locus in individuals included in the original genome-wide association study followed by the identification of missense or nonsense mutations that cosegregate with the increased risk for T2D. 16 Second, mutations or polymorphisms in human genes could result in a different or absence of a phenotype in the mouse and thus not translate between species. This would for example be the case when gene expression is different between human and mouse tissues, as we have observed for Tspan8: the human pancreas expresses appreciable amounts of TSPAN8 mRNA, whereas the expression of Tspan8 in mouse pancreas is virtually absent. Given the essential role of the pancreas in the regulation of circulating insulin and glucose levels, it is conceivable that mutations in human TSPAN8 could result in a glucose phenotype, whereas mutations in mouse Tspan8 would not. A third explanation would be that Tspan8 ablation does affect glucose metabolism in the mouse, but that the conditions under which these knockout mice were studied were not optimal to detect such differences. For example, a longer treatment with a high fat diet or different feeding conditions altogether could be required to detect an effect of Tspan8 ablation on the onset of T2D in mice. As discussed above, this is not very likely as we have successfully used this phenotyping paradigm to assess glucose metabolism differences in generated knockout mice. Although Tspan8 has been found to colocalize with a6b4 integrin, little is know about its physiological function. 31, 32 Increased expression of TSPAN8 has been found in human hepatocellular carcinomas and pancreatic adenocarcinomas and its association with a6b4 integrin suggested a role for TSPAN8 in the motility of cells and possibly the metastasis of tumors. [31] [32] [33] Recently, TSPAN8 was identified as an exosome component in the human colon cancer cell line HT29 by use of a mass spectrometry-based approach. 34, 35 Exosomes have been shown to have a role in communication processes between cells by transporting proteins and mRNA molecules that regulate gene expression in target cells. 36 Indeed, TSPAN8 was recently shown to contribute to the recruitment of proteins and mRNA into exosomes and induce angiogenesis in target tissues. 37 Currently, we do not know the mechanism by which Tspan8 deficiency results in lower body weight and lean and fat tissue mass gain in male knockout mice. However, given the expression of Tspan8 in the digestive tract and its occurrence in exosomes, one tempting hypothesis would be that Tspan8 is involved in the regulation of uptake of biomolecules from the diet. Tspan8 itself could be involved in the active uptake of biomolecules or it could facilitate the uptake of biomolecules by association with transporters in the plasma membrane. In this respect, it is interesting to note that tetraspanins are known to form complexes with different partner proteins in different cell types, thereby contributing to different physiological functions of these complexes. 38, 39 Alternatively, Tspan8 could indirectly alter the expression of genes in target cells that as a result alter their uptake of biomolecules from the diet. Such hypotheses could also offer an alternative explanation for how Tspan8 deficiency results in lower bone density in the mouse, as the uptake of minerals, such as calcium, from the diet could in part be regulated by Tspan8 and thus be compromised in Tspan8-deficient cells. The availability of these Tspan8 knockout mice should allow for testing of this and other hypotheses, for example by enabling RNA expression profiling experiments of target tissues or by performing more directed uptake or metabolic tracer studies in vivo. To use these Tspan8 knockout mice to study the physiological role of Tspan8 in insulin sensitivity and glucose metabolism in humans might be more difficult, however, given the discrepancy in Tspan8 expression in human and mouse pancreas. Only seven other tetraspanin gene family members have been knocked out in the mouse, [40] [41] [42] [43] [44] [45] [46] [47] with varying impact on the phenotype of the generated mice. In all cases, however, are the generated knockout mice viable and do not show major developmental abnormalities. Perhaps the most severe phenotype can be discerned in female CD9 and CD81 knockout mice, which are infertile due to a defect in sperm-egg fusion. 41, 42, 45 The underlying cause of this defect is most likely a disruption in the interaction between CD9 and CD81 with integrins, such as a3b1 and a6b1, which can A role for Tspan8 in body weight control M-F Champy et al interact with proteins present on the sperm. It is interesting that, although the fertility in CD9 knockout mice is severely, but not completely, impaired, CD9À/ÀCD81À/À double knockout mice are completely infertile. 45 It is surprising that mice defective for the tetraspanin CD151, which also directly associates with a3b1 and a6b1 integrin, show normal fertility but decreased blood coagulation and hyperproliferative T lymphocytes. 43 This latter phenotype can also be observed in knockout mice for the tetraspanins CD37,
48
Tssc6 49 and CD81. 50 Taken together, these published results suggest that tetraspanin family members can have complementary or partially overlapping roles in different physiological processes or that they merely facilitate physiological processes by enabling the interaction between essential protein components. They also show that ablation of these tetraspanins mostly leads to subtle, but significant, changes in the physiology of the mouse. The observed changes in Tspan8À/À mice that are described in this study are in line with those of previously generated tetraspanin knockout mice in the sense that they too are subtle and could, therefore, also be subjected to molecular redundancy or even compensation during the development of these knockout mice. They are the first example, however, of a tetraspanin that has a role in the regulation of body weight and form an ideal experimental tool in the study of the physiological function of Tspan8 in this process.
